Clinical Trial Update: ORal IrON Supplementation with Ferric Maltol in Treating Iron Deficiency and Anaemia in Patients with Heart Failure (ORION-HF) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial ORION-HF evaluating oral ferric maltol for iron deficiency anemia in patients with heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Iron Deficiency Anemia

Drugs mentioned

• Ferric Maltol (ferric maltol)

Snippet

Sponsor: Hannover Medical School | Conditions: Heart Failure, Left-sided, Anemia, Iron Deficiency | Phase 4 | Status: COMPLETED